OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Efficacy of Dupilumab in Children 6 Months to 11 Years Old With Atopic Dermatitis: A Retrospective Real-World Study in China
Nali Yang, Yahui Ye, Junyi Shao, et al.
Dermatitis (2023) Vol. 35, Iss. S1, pp. S39-S46
Closed Access | Times Cited: 13

Showing 13 citing articles:

Real-world outcomes of children treated with dupilumab for moderate-to-severe atopic dermatitis: a single-centre retrospective observational UK study
Mozhgan Hosseini-Ashrafi, Tim H Clayton, Michelle Herring, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 6, pp. 578-583
Open Access | Times Cited: 9

Real-world efficacy and safety of dupilumab in children with atopic dermatitis under 6 years of age: a retrospective multicentric study
Filip Rob, Blanka Pinková, K. Yu. Sokolova, et al.
Journal of Dermatological Treatment (2025) Vol. 36, Iss. 1
Open Access

A 52-week multicenter retrospective real-world study on effectiveness and safety of dupilumab in children with atopic dermatitis aged from 6 to 11 years
Cataldo Patruno, Gabriella Fabbrocini, Giuseppe Lauletta, et al.
Journal of Dermatological Treatment (2023) Vol. 34, Iss. 1
Open Access | Times Cited: 11

Monoclonal antibodies for moderate-to-severe atopic dermatitis: a look at phase III and beyond
Eden David, Kelly Hawkins, Neda Shokrian, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 471-489
Closed Access | Times Cited: 3

Effectiveness and Safety of Dupilumab in Children Under 6 Years of Age with Moderate-to-Severe Atopic Dermatitis: A Retrospective Real-World Study
Emilio Berna‐Rico, Esther Fiz Benito, José Manuel Busto‐Leis, et al.
Dermatology (2023) Vol. 240, Iss. 2, pp. 337-342
Open Access | Times Cited: 7

Dupilumab treatment in paediatric atopic dermatitis (2 to 18 years): Spanish multicentre retrospective real-life study
Helena Iznardo, Esther Roé, Asunción Vicente, et al.
Clinical and Experimental Dermatology (2024)
Closed Access | Times Cited: 1

Mid-Term Efficacy of Dupilumab in Children Aged ≥ 36 Months to <12 Years With Atopic Dermatitis: A Case Series
Francisco Javier Melgosa Ramos, Tania Díaz Corpas, Sergio Martín Jiménez, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 6, pp. 625-627
Open Access

Self-Assessment
Lawrence S. Feigenbaum, Jennifer K. Chen
Dermatitis (2024) Vol. 35, Iss. S1, pp. S1-S3
Closed Access

[Artículo traducido] Eficacia a medio plazo de dupilumab en niños de ≥ 36 meses a < 12 años con dermatitis atópica: serie de casos
Francisco Javier Melgosa Ramos, Tania Díaz Corpas, Sergio Martín Jiménez, et al.
Actas Dermo-Sifiliográficas (2024) Vol. 115, Iss. 6, pp. T625-T627
Open Access

Page 1

Scroll to top